Expand VCYT Menu
VCYT MENU

VCYT Latest Press Releases

-- September 14, 2026 --

Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform Globe Newswire 4:05 PM

-- September 1, 2026 --

Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Globe Newswire 4:05 PM

-- July 30, 2026 --

Veracyte Announces Second Quarter 2026 Financial Results Globe Newswire 4:05 PM

-- July 28, 2026 --

Veracyte to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- July 9, 2026 --

Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026 Business Wire 4:05 PM

-- June 1, 2026 --

Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S. Business Wire 7:30 AM

-- May 30, 2026 --

ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer Business Wire 8:00 AM

-- May 29, 2026 --

Landmark OPTIMA Trial Delivers Practice-Changing Evidence that Veracyte's Prosigna Test Identifies Patients with High-Risk Breast Cancer Who Can Safely Avoid Chemotherapy Business Wire 3:15 PM

-- May 22, 2026 --

Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings Business Wire 8:00 AM

-- May 21, 2026 --

OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer Business Wire 6:00 PM

-- May 19, 2026 --

Veracyte to Participate in Upcoming Investor Conferences Business Wire 4:05 PM

-- May 15, 2026 --

Veracyte Secures Medicare Coverage for TrueMRD Monitoring Test in Muscle-Invasive Bladder Cancer Business Wire 9:00 AM

-- May 13, 2026 --

A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech Globe Newswire 9:00 AM

-- May 5, 2026 --

Veracyte Announces First Quarter 2026 Financial Results Business Wire 4:05 PM

-- April 28, 2026 --

Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers Business Wire 9:00 AM
Market Data Delayed 15 Minutes